Pharmaceutical Technology

Tableting equipment in the high potency oral drug product manufacturing facility in Wuxi city, China. (Source: Wuxi STA)

Will we all get our personal medicine one day? (Bild: vrx123 - stock.adobe.com)

At an upcoming pharma event, Stäubli Robotics will showcase the flagship Stericlean+ TX2-60 robot for the first time within a new isolator cell. (Source: Stäubli Robotics)

The technologies produced at the Chelmsford site are used in the purification process of developing biotherapeutics and vaccines. (Source: ©copyright John Still for Thermo Fisher Scientific)

Berthold's measurement solutions offfer reliable and continuous online concentration measurement. (Source: Berthold Technologies)

GEA invests in a pharmaceutical technology center for freeze-drying systems. (Source: GEA)

Royal DSM has announced the completion of its acquisition of Prodap, a leading animal nutrition and technology company in Brazil, which was first announced on June 7, 2022. (Source: Pixabay)

The capsule filling machine installed at Aenova Münster is a Planeta 200, with a speed of 100.000 capsules/hour, later scalable up to 200.000 capsules/hour. (Source: MG2)

Stand vom 23.03.2021

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.